Growth Metrics

Tandem Diabetes Care (TNDM) Free Cash Flow (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 151.30%
Dec 31, 2025 -209.66%
Sep 30, 2025 211.88%
Jun 30, 2025 64.20%
Mar 31, 2025 -180.56%
Dec 31, 2024 22.41%
Sep 30, 2024 283.46%
Jun 30, 2024 5.72%
Mar 31, 2024 -208.83%
Dec 31, 2023 314.09%
Sep 30, 2023 71.04%
Jun 30, 2023 17.59%
Mar 31, 2023 -11,704.66%
Dec 31, 2022 -98.11%
Sep 30, 2022 296.18%
Jun 30, 2022 -146.75%
Mar 31, 2022 74.33%
Dec 31, 2021 -80.98%
Sep 30, 2021 14.59%
Jun 30, 2021 5.79%
Mar 31, 2021 76.00%
Dec 31, 2020 13.29%
Sep 30, 2020 -34.60%
Jun 30, 2020 177.70%
Mar 31, 2020 -1,248.24%
Dec 31, 2019 -88.51%
Sep 30, 2019 338.55%
Jun 30, 2019 185.63%
Mar 31, 2019 -149.38%
Dec 31, 2018 427.41%
Sep 30, 2018 48.14%
Jun 30, 2018 47.17%
Mar 31, 2018 27.75%
Dec 31, 2017 -14.98%
Sep 30, 2017 18.69%
Jun 30, 2017 12.12%
Mar 31, 2017 -28.89%
Dec 31, 2016 19.55%
Sep 30, 2016 -18.68%
Jun 30, 2016 -4.35%
Mar 31, 2016 -37.51%
Dec 31, 2015 29.58%
Sep 30, 2015 13.96%
Jun 30, 2015 -22.76%
Mar 31, 2015 -12.18%
Dec 31, 2014 1.84%
Sep 30, 2014 20.79%
Jun 30, 2014 1.13%
Mar 31, 2014 -29.87%
Dec 31, 2013 -18.54%
Sep 30, 2013 23.03%
Jun 30, 2013 -61.46%